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Abstract
Endurance exercise begun with reduced muscle glycogen stores seems to potentiate  
skeletal muscle protein abundance and gene expression. However, it is unknown 
whether this greater signaling responses is due to performing two exercise sessions 
in close proximity—as a first exercise session is necessary to reduce the muscle gly-
cogen stores. In the present study, we manipulated the recovery duration between a 
first muscle glycogen-depleting exercise and a second exercise session, such that the 
second exercise session started with reduced muscle glycogen in both approaches but 
was performed either 2 or 15 hours after the first exercise session (so-called “twice- 
a-day” and “once-daily” approaches, respectively). We found that exercise twice-a-day  
increased the nuclear abundance of transcription factor EB (TFEB) and nuclear factor of 
activated T cells (NFAT) and potentiated the transcription of peroxisome proliferator- 
activated receptor-ɣ coactivator 1-alpha (PGC-1α), peroxisome proliferator- 
activated receptor-alpha (PPARα), and peroxisome proliferator-activated receptor 
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1 |  INTRODUCTION
Endurance exercise is a powerful stimulus affecting cyto-
plasmic and nuclear proteins, and genes encoding mitochon-
drial proteins, with a subsequent increase in mitochondrial 
biogenesis (ie, the generation of new mitochondrial compo-
nents leading to increased mitochondrial content and respi-
ratory function).1-8 While these responses are affected by the 
nature of the exercise (eg, the exercise intensity2,9,10), there 
is evidence substrate availability is also a potent modulator 
of this response.11-14 It has been hypothesized that initiating 
endurance exercise with low muscle glycogen stores (the 
so-called “train-low” approach) results in a greater increase 
in the content of nuclear proteins15,16 and in the transcrip-
tion of genes17-20 associated with mitochondrial biogenesis. 
However, although the “train-low” strategy has been reported 
to potentiate skeletal muscle signaling responses related to 
mitochondrial biogenesis,17,21-23 there are also contrasting 
findings showing no effects24,25 and a consensus is yet to be 
reached.
Some of the evidence supporting the “train-low” approach 
is based on performing a first exercise session to reduce 
muscle glycogen stores, which is followed by a second ex-
ercise session 1-3  hours later—the so-called “twice-a-day” 
approach.21-24,26-28 Although the second exercise session will 
start with reduced muscle glycogen stores, it is difficult to 
determine if any changes are due to performing the second 
exercise session with low muscle glycogen or performing the 
second exercise session soon after the first. The transcrip-
tional responses of many genes associated with mitochon-
drial biogenesis peak approximately 3  hours post exercise 
and return to basal levels within 8-12 hours,5,14,29-32 including 
the transcription of peroxisome proliferator-activated 
receptor-ɣ coactivator 1-alpha (PGC-1α)—considered a key 
regulator of mitochondrial biogenesis.33 Thus, it is possible 
that reported increases in gene expression with the twice-
a-day approach can be attributed to performing the second 
exercise session close to the first, when there is an already 
increased expression of genes associated with mitochondrial 
biogenesis. In fact, recent findings suggest that improvements 
in mitochondrial efficiency after a 3-week train-low approach 
are linked to performing the second exercise session close to 
the first exercise session rather than due to reduced muscle 
glycogen per se.34 The molecular signaling responses asso-
ciated with this greater mitochondrial adaptation to twice- 
a-day training is, however, unknown.
The aim of this study was to investigate whether greater 
 exercise-induced signaling with the “train-low” approach 
can be attributed to the cumulative effects of performing two 
exercise sessions in close proximity. In the present study, we 
manipulated the recovery duration between a first muscle 
glycogen-depleting exercise and a second exercise session (ie, 
“once-daily” vs “twice-a-day” approach). In the once-daily 
condition, muscle glycogen content was reduced via evening 
exercise (prolonged exercise) followed by a carbohydrate- 
restricted period, and a second exercise (ie, high-intensity in-
terval exercise) was performed the next day (ie, 15 h between 
exercise sessions). In the twice-a-day condition, the same 
exercises were used but with a short recovery period between 
exercise sessions (ie, 2 h between exercise sessions). A high- 
intensity interval exercise session undertaken without a prior 
muscle glycogen-depleting exercise served as a control. We 
hypothesized that the “twice-a-day” approach would induce a 
more elevated molecular signaling response during the second 
exercise session, compared to the “once-daily” approach.
2 |  MATERIALS AND METHODS
2.1 | Participants
Eight healthy men (age: 30.8  ±  3.5  years, body mass: 
78.7 ± 9.9 kg, height: 1.76 ± 0.07 m, body fat: 13.6 ± 5.1%, 
peak oxygen uptake [V̇O2peak]: 37.1 ± 6.4 mL·kg−1·min−1, peak 
power derived from a graded exercise test: 229.6 ± 38.2 W, 
and first and second lactate thresholds: 78.1  ±  20.9 and 
170.0  ±  37.7  W, respectively) participated in this study. 
Participants were recruited by word-of-mouth conversations, 
online postings, and flyers posted at the University Campus. 
Participants were considered eligible if they were physically 
beta/delta (PPARβ/δ) genes, in comparison with the once-daily exercise. These re-
sults suggest that part of the elevated molecular signaling reported with previous 
“train-low” approaches might be attributed to performing two exercise sessions in 
close proximity. The twice-a-day approach might be an effective strategy to induce 
adaptations related to mitochondrial biogenesis and fat oxidation.
K E Y W O R D S
high-intensity exercise, mitochondrial biogenesis, molecular signaling, muscle glycogen, transcription 
factor
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active (more than 3 times/week) and accustomed to cycling. 
Participants were excluded if they had history or signs of car-
diac, metabolic, or respiratory diseases and/or had been using 
any prescription medications. A medical doctor administered 
a medical history screening tool for this purpose. Participants 
were informed about the procedures, risks, and benefits as-
sociated with the protocol, before they signed a consent form 
agreeing to participate in this study, which was approved 
by the Research Ethics Committee of Federal University of 
Pernambuco (approval number: 30378414.8.0000.5208). The 
study was conducted according to the principles presented in 
the Declaration of Helsinki.
Sample size was calculated using G*Power software 
(Heinrich-Heine-University Düsseldorf, version 3.1.9.2, 
Düsseldorf, Germany), assuming an effect of exercising 
with reduced muscle glycogen content on PGC-1α mRNA 
expression of 1.34,17 an alpha of 0.05, and a desired power 
of at least 0.80. We used PGC-1α mRNA expression as the 
main primary outcome as this gene has been considered a 
key regulator of mitochondrial biogenesis.33 The effective 
sample size necessary to achieve statistical significance was 
six participants; however, sample size was increased to eight 
participants to account for potential dropouts or insufficient 
muscle sample size due to technical problems.
2.2 | Study overview
Each participant completed three experimental trials in 
a crossover, randomized, and incomplete balanced Latin 
Square counterbalanced measure design. The randomization 
was performed using software available at http://www.rando 
mized.org and controlled by an investigator of our laboratory 
who was not conscious of the aim of the study. All tests 
were performed at Vitória Santo Antão Campus of Federal 
University of Pernambuco from March to November 2015.
An overview of the experimental design is shown 
in Figure 1. Briefly, in the once-daily approach partici-
pants performed the muscle glycogen-depleting exercise 
in the evening (20:00-22:00  h) followed by an overnight 
fast. The next morning (08:00  h), participants ate a low- 
carbohydrate breakfast (carbohydrate: 42.7 ± 5.0 kcal, 7%; 
fat: 365.9 ± 43.1 kcal, 60%; protein: 201.3 ± 23.7 kcal, 33%) 
and then performed the high-intensity interval exercise ses-
sion in the afternoon (13:00 h). In the twice-a-day approach, 
participants ate a low-carbohydrate breakfast on the morn-
ing of the experimental day (08:00 h), and then performed 
a muscle glycogen-depleting exercise (09:00-11:00  h), fol-
lowed by a 2-hour rest period and the high-intensity interval 
exercise (13:00 h). In the control condition, participants con-
sumed the same low-carbohydrate breakfast as the two other 
experimental trials (08:00 h), and then performed the same 
high-intensity interval exercise session in the afternoon (ie, 
13:00 h). Skeletal muscle biopsies from the vastus lateralis 
and venous blood samples were taken before, immediately 
after, and 3 hours after completion of the high-intensity in-
terval exercise sessions. Participants were not allowed to eat 
any food between the breakfast and the last muscle biopsy 
in all experimental trials. Water was provided ad libitum 
throughout each trial. Each experimental trial was separated 
by approximately 2 weeks to washout any residual effect of 
fatigue or damage caused by exercise and the multiple muscle 
biopsies. The main primary outcome measure was PGC-1α 
mRNA, while the second outcome measures were nuclear/
cytosolic proteins and other genes associated with mitochon-
drial biogenesis.
F I G U R E  1  Experimental design. D, dinner; B, breakfast; L, lunch; MG-DE, muscle glycogen-depleting exercise; HIIE, high-intensity 
interval exercise. Open-dashed circles indicate that participants replicated their usual diet, while closed circles indicate that participants ate a 
low-carbohydrate (CHO) breakfast (CHO: 42.7 ± 5.0 kcal [~7%], fat: 365.9 ± 43.1 kcal [~60%], protein: 201.3 ± 23.7 kcal [~33%]). Black arrows 
indicate time point when muscle biopsies and blood samples were taken
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2.3 | Exercise protocols
2.3.1 | Preliminary test
One week prior to the commencement of this study, partici-
pants performed a graded exercise test to volitional fatigue 
on a cycloergometer (Ergo-Fit 167, Pirmasens, Germany). 
The test commenced at 50 W, and thereafter intensity was 
increased by 25 W every 4 minutes, with a 1-minute break 
between stages, until volitional exhaustion.35 The test was 
interrupted when the participant could no longer maintain 
the required cadence (70 rpm). Strong verbal encouragement 
was provided to each participant.
V̇O2 was measured breath-by-breath throughout the test 
using an automatic analyzer (Cortex, Metalyzer 3B, Saxony, 
Germany). Before each test, the gas analyzer was calibrated 
using ambient air and a cylinder of known gas concentration 
(12% O2 and 5% CO2). The volume was calibrated using a 3-L 
syringe (Quinton Instruments, Washington, US). Capillary 
ear lobe blood samples were taken at rest and immediately 
after each 4-minute stage of the test for determination of 
plasma lactate concentration. The first lactate threshold was 
visually identified by two experienced investigators as the 
first increase in plasma lactate concentration above resting 
level. The second lactate threshold was calculated by the 
modified Dmax method.36 This was determined by the point 
on the polynomial regression curve that yields the maximal 
perpendicular distance to the straight line connecting the first 
lactate threshold and the final stage of the test. V̇O2peak was 
defined as the highest 30-second average V̇O2 during the 
test and peak power was determined as the highest workload 
reached. If a participant did not complete the final 4-minute 
stage, then the peak power was determined using the follow-
ing equation:
where Plast is the power in Watts of the last completed stage 
performed by the participant, t is the time (in seconds) sus-
tained during the last incomplete stage, and 25 corresponds to 
the increments in power (Watts) at each stage.
2.3.2 | Muscle glycogen-depleting exercise
To reduce muscle glycogen stores, participants cycled for 
100  minutes at a power corresponding to 50% of the dif-
ference between their first and second lactate thresholds 
(124  ±  27  W, 54  ±  5% of peak power). Then, after an 
8-minute rest, participants performed six 1-minute exercise 
bouts at 125% of their peak power (287 ± 46 W) interspersed 
with 1-minutes rest periods.37 This protocol has been shown 
to be effective to reduce muscle glycogen content.38,39
2.3.3 | High-intensity interval exercise
The high-intensity interval exercise sessions were preceded 
by a 5-minute warm-up at 90% of the first lactate threshold. 
Participants completed ten 2-minute intervals at an intensity 
of 20% of the difference between the second lactate threshold 
and their peak power (182 ± 38 W, 79 ± 5% of peak power). 
Each 2-minute bout was interspersed with a 1-minute passive 
recovery period.35 Participants were required to maintain a 
pedal frequency of 70-80 rpm during each 2-minute bout. The 
V̇O2, V̇CO2, RER, and V̇E were measured breath-by-breath 
throughout each high-intensity interval exercise session using 
the same gas analyzer described for the graded exercise test. 
Data were then converted to 30-second intervals and the last 
30 seconds of each 2-minute bout were used for further analysis.
2.4 | Diet and exercise control before 
starting experimental manipulation
Participants were asked to register all foods and beverages con-
sumed during the 48-hour preceding the start of the preliminary 
test. The usual macronutrient consumption was measured from 
this diet recall using a computer program designed to perform 
nutritional calculations (Nutwin, Nutrition Support Program, 
version 1.5, Department of Health Informatics, Federal 
University of São Paulo, Brazil). The daily energy and macro-
nutrient intakes during the 48-hour preceding the first prelimi-
nary test were 3330 ± 475 kcal (43.2 ± 10.0 kcal·kg−1), 49% ± 
6% carbohydrates (409.3 ± 79.4 g, 5.3 ± 1.4 g·kg−1), 27% ± 5% 
lipids (101.5 ± 28.2 g, 1.3 ± 0.5 g·kg−1), and 24% ± 7% protein 
(195.0 ± 43.8 g, 2.5 ± 0.5 g·kg−1). Participants were asked to 
replicate the dinner of two days before (day 1), and breakfast, 
lunch and dinner of one day before the experimental trial (day 2) 
(Figure 1). Participants were given verbal and written instruc-
tions describing how to repeat this before each subsequent 
experimental trial. Checklists were used to check any devia-
tions from the menu, and analysis of checklists showed no dif-
ferences for energy or macronutrient intake between conditions 
during these meals (Table 1). Participants were also instructed 
to avoid any strenuous exercise as well as alcohol and caffeine 
consumption for the 24 hours prior to each experimental trial.
2.5 | Blood collection and analysis
Blood samples were collected from an antecubital vein and 
separated into three different tubes. Two milliliters of blood 
were collected in tubes containing sodium fluoride and EDTA 
(Hemogard Fluoride/EDTA, BD Vacutainer, USA). Blood was 
centrifuged at 4000 rev·min−1 for 10 minutes at 4°C with the 
resulting plasma transferred to 2-mL tubes and immediately 
analyzed for plasma glucose and lactate concentrations. Plasma 
(1)Peak power =Plast+ (t∕240 ⋅25)
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glucose and lactate concentrations were analyzed with a com-
mercially available enzymatic kit (Glucose Liquiform and 
Enzymatic Lactate, respectively, Labtest, Lagoa Santa, Minas 
Gerais, Brazil). A further 8 mL of blood was collected in tubes 
containing Clot activator and gel for serum separation (SST II 
Plus, BD Vacutainer, USA), and another 3 mL of blood was 
collected in tubes containing sodium heparin (Sodium HeparinN 
Plus, BD Vacutainer, USA). Both were then centrifuged at 
4000 rev·min−1 for 10 minutes at 4°C, and the resulting serum/
plasma frozen and stored in liquid nitrogen for the later analysis 
of free fatty acid, glycerol, and catecholamine concentrations in 
the serum/plasma. Serum free fatty acid and glycerol concen-
trations were determined by an enzymatic colorimetric method 
(EFFA-100 and EGLY-200, BioAssay, Hayward, California, 
USA). Plasma catecholamine concentrations were determined 
using ion-pairing reverse phase liquid chromatography coupled 
with electrochemical detection.37
2.6 | Muscle tissue samples and analysis
Nine separate incisions (three per trial) were made into the 
vastus lateralis under local anaesthesia (2% Xylestesin), and 
a muscle sample taken using a Bergström needle40 adapted 
for manual suction.41 Samples were taken approximately 
1  cm apart from a previous biopsy site. Samples (mean: 
118  ±  48  mg; range: 49-248  mg) were immediately snap-
frozen in liquid nitrogen, and then stored at −80ºC until 
subsequent analyses. Muscle samples were taken at rest (pre), 
immediately after (post) and 3 hours after the high-intensity 
interval exercise (3 h post). Biopsies were subsequently ana-
lysed for muscle glycogen content, as well as gene and pro-
tein expression (described subsequently).
2.7 | Muscle glycogen concentration
Approximately 2-3  mg of freeze-dried muscle tissue was 
powdered and dissected free of all visible nonmuscle tissue. 
Powdered muscle tissue was then extracted with 250 µL of 
2 M HCl, incubated at 95°C for 2 hours (agitated gently every 
20 min), and then neutralized with 750 µL of 0.66 M NaOH. 
Glycogen concentration was subsequently assayed in triplicate 
via enzymatic analysis with fluorometric detection42 and the 
mean value reported as millimoles per kilogram dry weight.
2.8 | Western blotting
2.8.1 | Muscle homogenate preparations and 
protein assays
Approximately 20 mg of frozen muscle tissue was homoge-
nized using a TissueLyser II (Qiagen, Valencia, CA) in a 1:20 
dilution of ice-cold RIPA buffer (pH 7.4) containing: 0.15 M 
NaCl, 1% Triton-X100, 0.5% sodium deoxycholate, 0.05 M 
T A B L E  1  Analysis of checklists for energy or macronutrient intake between conditions for the dinner eaten 2 days before, and breakfast, 
lunch, and dinner eaten 1 day before the experimental trial
Dinner 2 days before the 
experimental trial
Breakfast 1 day before 
the experimental trial
Lunch 1 day before the 
experimental trial
Dinner 1 day before the 
experimental trial
Energy intake (Kcal)
Control 911 ± 348 613 ± 358 955 ± 233 852 ± 215
Twice-a-day 918 ± 354 602 ± 366 925 ± 236 886 ± 237
Once-daily 887 ± 334 602 ± 366 948 ± 236 884 ± 236
Carbohydrate (%)
Control 45 ± 19 52 ± 12 44 ± 5 50 ± 9
Twice-a-day 45 ± 19 53 ± 12 46 ± 6 49 ± 9
Once-daily 43 ± 18 53 ± 12 44 ± 5 49 ± 9
Protein (%)
Control 28 ± 17 17 ± 8 32 ± 5 21 ± 12
Twice-a-day 28 ± 17 17 ± 8 33 ± 6 21 ± 12
Once-daily 28 ± 17 17 ± 8 34 ± 7 21 ± 12
Lipids (%)
Control 27 ± 10 31 ± 7 23 ± 10 29 ± 8
Twice-a-day 27 ± 10 30 ± 8 21 ± 11 30 ± 9
Once-daily 30 ± 10 30 ± 8 21 ± 11 30 ± 9
Note: Data are presented as mean ± standard deviation. n = 8 for all variables.
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Tris, 0.1% SDS, 0.1 M EDTA, with the addition of protease/
phosphatase inhibitor cocktail (Cell Signaling Technology 
[CST], #5872, St. Louis, MI). Homogenates were rotated end-
over-end for 60 minutes at 4°C. Protein content of muscle ho-
mogenate was measured in triplicate using a Bradford assay 
(Bio-Rad protein assay dye reagent concentrate, Bio-Rad 
Laboratories, Hercules, CA) against bovine serum albumin 
standards (BSA, A9647, Sigma-Aldrich). Nuclear and crude 
cytosolic fractions were prepared from 40 to 60 mg of wet 
muscle using a commercially available nuclear extraction kit 
(NE-PER, Pierce, USA). Muscle samples were homogenized 
in cytoplasmic extraction reagent I buffer containing a pro-
tease/phosphatase inhibitor cocktail (CST, 5872). Following 
centrifugation (16 000 g for 5 min at 4°C), the supernatant was 
taken and pellets containing nuclei were washed 5 times in 
PBS to remove cytosolic contamination, before nuclear pro-
teins were extracted by centrifugation (16 000 g for 10 min 
at 4°C) in high-salt nuclear extraction reagent buffer supple-
mented with the same inhibitors cocktail following manufac-
turer's instruction. Verification of subcellular enrichment is 
presented in Figures 3B and 4B. Sufficient muscle was availa-
ble to prepare subcellular fractions from all eight participants.
2.8.2 | Immunoblotting
RIPA-buffered homogenate was diluted in 4X Laemmli buffer 
(0. 25 M Tris, 8% SDS, 40% glycerol, 0.04% bromophenol 
blue, 20% 2-mercaptoethanol) and equal amounts of total 
protein (10-20 µg) were loaded on Criterion 4%-20% TGX 
Stain-Free Precast Gels (Bio-Rad). All samples for a partici-
pant were loaded in adjacent lanes on the same gel. Four to six 
different dilutions of a mixed-homogenate internal standard 
were also loaded on each gel and a calibration curve plotted 
of density against protein content. From the subsequent linear 
regression equation protein abundance was calculated from 
the measured band intensity for each sample on the gel.43 Gel 
electrophoresis ran for 90 minutes at 80-150 V. Proteins were 
turbo-transferred to a 0.2-µm PVDF membrane at 25 V for 
10 minutes. Membranes were blocked for 60 minutes at room 
temperature in 5% nonfat dry milk diluted in Tris-buffered 
saline with 0.1% Tween-20 (TBST). Membranes were then 
washed in TBST and incubated overnight at 4°C—with the 
appropriate primary antibody: Histone H3 (CST, 44  995), 
LDHA (CST, 2012), PGC-1α (CST, 2178), p-ACCSer79 (CST, 
3361), 5′ adenosine monophosphate-activated protein kinase 
(AMPK) (CST, 2532), p-AMPKThr172 (CST, 2531), p38 
MAPK (CST, 9212), p-p38 MAPKThr180/Tyr182 (CST, 9211), 
PHF20 (CST, 3934), p53 (CST, 2527), TFEB (CST, 9601), 
and NFAT2 (CST, 8032) diluted (1:1000) in 5% BSA and 
0.02% sodium azide in TBST. Following TBST washes the 
membranes were incubated in the relevant secondary anti-
body: Goat anti-rabbit IgG (Perkin Elmer/NEF812001EA), 
diluted (1:10 000) in 5% nonfat dry milk in TBST, for 60 min-
utes at room temperature. After further washes, membranes 
were developed using Clarity ECL (Bio-Rad) and images 
were taken with a ChemiDoc Imaging System fitted (Bio-
Rad). Densitometry was performed with Image Lab 5.0 soft-
ware (Bio-Rad). Images are typically displayed with at least 
five bandwidths above and below the band of interest.
2.9 | Real-Time quantitative PCR
2.9.1 | RNA extraction
Total RNA from approximately 10-15  mg of frozen mus-
cle was homogenized in 800 µL of TRIzol reagent (Thermo 
Fisher Scientific, Waltham, USA) using a TissueLyser II 
(Qiagen).44 The concentration and purity of each sample 
was assessed using a NanoDrop One/Onec (Thermo Fisher 
Scientific). RNA integrity of a subset of samples was meas-
ured using a Bio-Rad Experion microfluidic gel electro-
phoresis system with Experion RNA StdSens Analysis kit 
(Bio-Rad, 7 007 104). All tested samples showed good qual-
ity (RNA quality indicator >7). RNA was stored at −80°C 
until reverse transcription was performed.
2.9.2 | Reverse transcription
1 µg RNA, in a total reaction volume of 20 µL, was reverse tran-
scribed to cDNA using a Thermocycler (Bio-Rad) and iScript 
RT Supermix (Bio-Rad, 170-8840) per the manufacturer's 
instructions. Priming was performed at 25°C for 5  minutes 
and reverse transcription for 30 minutes at 42°C. All samples, 
including RT-negative controls, were performed during the 
same run. cDNA was stored at −20°C until subsequent analysis.
2.9.3 | qPCR
Relative mRNA expression was measured by qPCR 
(QuantStudio 7 Flex, Applied Biosystems, Foster City, CA) 
using SsoAdvanced Universal SYBR Green Supermix (Bio-
Rad). Primers were designed using Primer-BLAST45 to 
include all splice variants, and were purchased from Sigma-
Aldrich (see Table S1 for primer details). All reactions were 
performed in duplicate on 384-well MicroAmp optical plates 
(4 309 849, Applied Biosystems) using an epMotion M5073 
automated pipetting system (Eppendorf AG). Total reaction 
volume of 5  µL contained 2  µL of diluted cDNA template, 
2.5 µL of mastermix, and 0.3 µM or 0.9 µM primers. All assays 
ran for 10 minutes at 95°C, followed by 40 cycles of 15 seconds 
at 95°C and 60 seconds at 60°C. The stability of six poten-
tial reference genes were determined by BestKeeper46 and 
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NormFinder47 software, and the three most stably expressed 
genes were TATA box-binding protein (TBP), 18S ribosomal 
RNA (18S), and actin beta (ACTB) (Table S1). There were no 
main effects of training approach, time, nor interaction effects, 
for the quantification cycle (Ct) values of the three most stable 
housekeeping genes (P > .05). Expression of each target gene 
was normalized to the geometric mean of expression of the 
three reference genes,48 and using the 2−ΔΔCt method.49
2.10 | Statistical analysis
Statistical analysis was performed using the GraphPad Prism 
software version 6.01. All data were checked for normal-
ity with the Kolomogorov-Smirnov test. To compare the 
responses before, immediately after, and 3 hours after each 
high-intensity interval exercise session, data were analyzed 
with two-way repeated measures ANOVA (trial vs. time). A 
Bonferroni post hoc test was used to locate the differences. 
All values are expressed as means ± SD. Significance was 
accepted when P < .05.
3 |  RESULTS
3.1 | Muscle glycogen concentration
Prior to the high-intensity interval exercise, muscle glycogen 
concentration was similarly lower in both the twice-a-day 
and once-daily conditions, compared to the control condi-
tion (~45% and 42%, respectively; Figure 2). Compared to 
their respective rest values, muscle glycogen concentration 
decreased similarly after the high-intensity interval exercise 
in all three conditions (from 245.0 to 135.7 mmol·kg−1 dry 
mass in the twice-a-day, from 262.2 to 163.7 mmol·kg−1 dry 
mass in the once-daily, and from 449.2 to 312.2 mmol·kg−1 
dry mass in the control; ~45%, 38%, and 30% of reduction for 
twice-a-day, once-daily and control, respectively; P  <  .05; 
Figure 2), and remained lower 3 hours postexercise in both 
the twice-a-day and once-daily conditions, compared to the 
control condition (~46% and 43%, respectively; Figure 2).
3.2 | Cytosolic proteins relative abundance
Representative blots are presented in Figure 3A,B. Cytosolic p53 
protein relative abundance increased immediately post the high-
intensity interval exercise in all three conditions (Figure 3D), 
with no differences between conditions. Cytosolic PGC-1α, 
phosphorylated p53 (p-p53Ser15), PHF20 protein (PHF20), 
TFEB, p38 mitogen-activated protein kinase (p38 MAPK), 
phosphorylated 5′ adenosine monophosphate-activated protein 
kinase (p-AMPKThr172), and NFAT relative abundance were un-
affected by the exercise approach or time (Figure 3C,E-J).
3.3 | Nuclear protein relative abundance
Representative blots are presented in Figure 4A,B. Nuclear 
PGC-1α, p53, and p-p53Ser15 relative abundance increased 
post the high-intensity interval exercise (Figure 4C-E), with 
no clear differences between the three conditions. The relative 
abundance of nuclear PHF20, p38MAPK, and p-AMPKThr172 
was unaffected by either “train-low” approach or time 
(Figure 4F-H). However, nuclear TFEB relative abundance 
was greater in the twice-a-day compared to the once-daily 
condition both pre and post the high-intensity interval 
exercise (Figure 4I). Moreover, nuclear NFAT relative abun-
dance was also greater in the twice-a-day compared to both 
the once-daily and control condition post the high-intensity 
interval exercise (Figure 4J).
3.4 | Mitochondrial-related gene expression
Pre the high-intensity interval exercise, total PGC-1α mRNA 
content was ~9-fold higher in the twice-a-day compared 
to both the once-daily and control conditions (Figure 5A). 
Three hours post the high-intensity interval exercise, total 
PGC-1α mRNA content increased in all three conditions 
compared with their respective pre  values; however, total 
PGC-1α mRNA content remained ~10-fold higher in the 
twice-a-day compared to both control and once-daily con-
ditions. Similarly, PGC-1α isoform 4 mRNA content was 
~24-fold higher at pre the high-intensity interval exercise in 
F I G U R E  2  Muscle glycogen concentration pre-, post-, and 
3 h post the high-intensity interval exercise. Data are presented as 
mean ± standard deviation. n = 8. *Significantly lower than control at 
the same time point (P < .05). #Significantly lower than pre the high-
intensity interval exercise for the same condition (P < .05). Two-way 
analysis of variance (ANOVA) with Bonferroni post hoc test
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the twice-a-day compared to both the once-daily and control 
conditions (Figure 5C). At 3 hours posthigh-intensity interval 
exercise, the PGC-1α isoform 4 mRNA content increased in 
all three conditions compared with their respective prevalues; 
however, the PGC-1α isoform 4 mRNA content remained 
~10-fold higher in the twice-a-day compared to the control 
and once-daily conditions. Additionally, PGC-1α isoform 1 
mRNA content was higher in the twice-a-day compared to the 
once-daily when all time points where considered (Figure 5B). 
There was no effect of condition for p53, TFEB, chromo-
domain-helicase-DNA-binding protein 4 (CHCHD4), p21, 
mitochondrial transcription factor A (Tfam), NADH dehy-
drogenase subunit β (NDUFβ; mitochondrial complex I), 
succinate dehydrogenase subunit β (SDHβ; mitochondrial 
F I G U R E  3  Cytosolic protein relative abundance pre and post the high-intensity interval exercise. A, Representative immunoblots 
corresponding to total and phosphorylated protein relative abundance measured in the cytosolic fraction, pre and post the high-intensity interval 
exercise in the control, twice-a-day, and once-daily approaches. B, LDHA was used as an indicator of cytosolic enrichment. N: nuclear fractions; 
C: cytosolic fractions; C, cytosolic peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1α); D, cytosolic p53 (p53); E, cytosolic 
phosphorylated p53 (p-p53Ser15); F, cytosolic PHF20 (PHF20); G, cytosolic phosphorylated 5′ adenosine monophosphate-activated protein kinase 
(p-AMPKThr172); H, cytosolic phosphorylated p38 mitogen-activated protein kinase (p-p38MAPK); I, cytosolic transcription elongation factor 
EB (TFEB); J, cytosolic nuclear factor of activated T cells (NFAT). n = 8 for all proteins. Data are presented as fold changes from control pre 
(mean ± standard deviation). #Significantly higher than pre the high-intensity interval exercise for the same condition (P < .05). Two-way analysis 
of variance (ANOVA) with Bonferroni post hoc test
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complex II), cytochrome c (mitochondrial complex III), and 
cytochrome c oxidase subunit IV (COX IV; mitochondrial 
complex IV) mRNA content post  the  high-intensity inter-
val exercise (Figure 5D-L). However, the mRNA content of 
representative subunits of mitochondrial complexes II, III, 
and IV increased 3  hours post  the  high-intensity interval 
exercise to a similar extent for all three conditions.
3.5 | Fat transport and lipolysis-
related genes
The content of carnitine palmitoyltransferase I subunit A 
(CPT1A) mRNA was higher in both the twice-a-day and 
once-daily conditions compared with the control condition 
at 3 hours post the high-intensity interval exercise; however, 
F I G U R E  4  Nuclear protein relative abundance pre and post the high-intensity interval exercise. A, Representative immunoblots 
corresponding to total and phosphorylated protein relative abundance measured in the nuclear fraction, pre and post the high-intensity interval 
exercise in the control, twice-a-day, and once-daily approaches. B, H3 was used as an indicator of nuclear enrichment. N: nuclear fractions; 
C: cytosolic fractions; C, nuclear peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1α); D, nuclear p53 (p53); E, nuclear 
phosphorylated p53 (p-p53Ser15); F, nuclear PHF20 (PHF20); G, nuclear phosphorylated AMPKThr172 (p-AMPKThr172); H, nuclear phosphorylated 
p38MAPK (p-p38MAPK); I, nuclear transcription elongation factor EB (TFEB); J, nuclear factor of activated T cells (NFAT). n = 8 for all 
proteins. Data are presented as fold changes from control pre (mean ± standard deviation). *Significantly higher than the once-daily and control 
condition at the same time point (P < .05). †Significantly higher than the once-daily condition at the same time point (P < .05). #Significantly 
higher than pre high-intensity interval exercise for the same condition (P < .05). Two-way analysis of variance (ANOVA) with Bonferroni post hoc 
test
   | 1611ANDRADE-SOUZA Et Al.
F I G U R E  5  Mitochondrial-related gene expression pre-, post-, and 3 h post the high-intensity interval exercise. A, peroxisome proliferator-
activated receptor-γ coactivator-1 (PGC-1α) total gene expression; B, PGC-1α isoform 1 gene expression; C, PGC-1α isoform 4 gene expression; 
D, p53 (p53) gene expression; E, transcription elongation factor EB (TFEB) gene expression; F, Chromodomain-helicase-DNA-binding protein 
4 (CHCHD4) gene expression; G, p21 protein (p21) gene expression; H, mitochondrial transcription factor A (Tfam) gene expression; I, NADH 
dehydrogenase (NDUFβ) (mitochondrial complex I) gene expression; J, succinate dehydrogenase subunit β (SDHβ) (mitochondrial complex II) 
gene expression; K, cytochrome c (mitochondrial complex III) gene expression; L, cytochrome c oxidase subunit IV (COXIV) (mitochondrial 
complex III) gene expression. n = 8 for all genes (except Tfam, n = 7). Data are presented as fold changes from control pre (mean ± standard 
deviation). *Significantly higher than the once-daily and control condition at the same time point (P < .05). #Significantly higher than prehigh-
intensity interval exercise for the same condition (P < .05). ɸSignificantly higher than posthigh-intensity interval exercise for the same condition 
(P < .05). Two-way analysis of variance (ANOVA) with Bonferroni post hoc test
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there was no difference between the two “train-low” ap-
proaches (Figure 6A). There was an increase in mitochon-
drial uncoupling protein 3 (UCP3) mRNA content 3  hours 
post exercise in all three conditions. The UCP3 mRNA con-
tent was, however, significantly higher only in the twice-a-day 
compared to the control condition at 3 hours post the high-
intensity interval exercise (Figure 6B). Pre the high-intensity 
interval exercise, the PPARα mRNA content was ~11-fold 
higher in the twice-a-day compared to both the once-daily 
and control conditions (Figure 6C). Three hours post the 
high-intensity interval exercise, the PPARα mRNA content 
increased ~7- and 9-folds in the once-daily and control condi-
tions, respectively, compared with their respective pre-values; 
however, the PPARα mRNA content remained ~16-fold 
higher in the twice-a-day compared to the once-daily and 
control conditions. The PPARβ/δ mRNA content was higher 
in the twice-a-day than in the control condition post the high-
intensity interval exercise, and higher than both the once-
daily and control conditions at 3 hours post the high-intensity 
interval exercise (Figure 6D). The PPARβ/δ mRNA content 
was higher at 3 hours post the high-intensity interval exercise 
compared to pre and post only for the twice-a-day approach. 
The citrate synthase (CS) mRNA content was higher 3 hours 
post the high-intensity interval exercise compared to post for 
all three conditions. However, the peroxisome proliferator-
activated receptor gamma (PPARγ), β-hydroxyacyl-CoA 
F I G U R E  6  Genes-related to fat transport and lipolysis pre-, post-, and 3 h post the high-intensity interval exercise. A, carnitine 
palmitoyltransferase I (CPT1) gene expression; B, mitochondrial uncoupling protein 3 (UCP3) gene expression; C, peroxisome proliferator-
activated receptor α (PPARα) gene expression; D, peroxisome proliferator-activated receptor β/δ (PPARβ/δ) gene expression; E, peroxisome 
proliferator-activated receptor γ (PPARγ) gene expression; F, citrate synthase (CS) gene expression; G, β-hydroxyacyl-CoA dehydrogenase 
(β-HAD) gene expression; H, fatty acid translocase cluster of differentiation 36 (CD-36) gene expression. n = 8 for all genes (except CS and UCP3, 
where n = 7). Data are presented as fold changes from control pre (mean ± standard deviation). *Significantly higher than the once-daily condition 
at the same time point (P < .05). †Significantly higher than the control condition at the same time point (P < .05). #Significantly higher than 
pre the high-intensity interval exercise for the same condition (P < .05). ɸSignificantly higher than post the high-intensity interval exercise for the 
same condition (P < .05). Two-way analysis of variance (ANOVA) with Bonferroni post hoc test
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dehydrogenase (β-HAD), and fatty acid translocase cluster of 
differentiation 36 (CD-36) mRNA content were unaffected by 
the “train-low” approach or time (Figure 6E-H).
3.6 | Glycolysis-related genes
The mRNA content of phosphofructokinase (PFK) and glu-
cose transporter 4 (GLUT4) was unaffected by the exercise 
approach or time. While pyruvate dehydrogenase kinase iso-
enzyme 4 (PDK4) mRNA content increased 3 hours post the 
high-intensity interval exercise, there was no difference for 
the three different exercise approaches (Figure 7A-C).
3.7 | Physiological responses
The twice-a-day approach was associated with a higher 
heart rate, ventilation, and oxygen uptake, and a lower 
plasma glucose concentration, during high-intensity in-
terval exercise than both the once-daily and the control 
condition (Figure 8A-C and Table 2). Plasma glucose was 
F I G U R E  7  Genes related to carbohydrate metabolism pre-, post-, and 3 h post the high-intensity interval exercise. A, phosphofructokinase 
(PFK) gene expression; B, glucose transporter 4 (GLUT4) gene expression; C, pyruvate dehydrogenase kinase isoenzyme 4 (PDK4) gene 
expression. n = 8 for all genes. Data presented as fold changes from control pre (mean ± standard deviation). #Significantly higher than prehigh-
intensity interval exercise for the same condition (P < .05). Two-way analysis of variance (ANOVA) with Bonferroni post hoc test
F I G U R E  8  Physiological and systemic responses during the high-intensity interval exercise. A, Heart rate (HR); B, Ventilation (V̇E); C, 
Oxygen uptake (V̇O
2
); D, Respiratory exchange ratio (RER). n = 8 for all variables. Data are presented as mean ± standard deviation. Time effect 
has been omitted for clarity. INT: Interval. Two-way analysis of variance (ANOVA) with Bonferroni post hoc test
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also lower during the high-intensity interval exercise in the 
once-daily compared to the control condition (Table 2). In 
addition, the respiratory exchange ratio was lower and the 
serum-free fatty acid concentration higher than the control 
only for the twice-a-day approach (Figure 8D and Table 2). 
Serum glycerol was higher and plasma lactate lower post 
the high-intensity interval exercise in both the twice-a-day 
and once-daily conditions compared with the control con-
dition (Table 2). Plasma epinephrine and norepinephrine 
concentrations were not influenced by the exercise ap-
proach undertaken.
4 |  DISCUSSION
There is continued debate about whether beginning exercise 
with low muscle glycogen stores potentiates the exercise-
induced increase in genes associated with mitochondrial bi-
ogenesis and metabolism.11,12,50-54 Some of this controversy 
may relate to the observation that some of the evidence sup-
porting the “train-low” approach is based on performing the 
experimental exercise session a few hours after a glycogen-
lowering exercise session.21-24,26-28 Thus, it is difficult to 
determine if any observed effects are due to performing the 
T A B L E  2  Plasma lactate, glucose, epinephrine and norepinephrine concentrations, and serum-free fatty acid and glycerol concentrations pre-, 
post- and 3 h post the high-intensity interval exercise
Pre Post 3 h post
Plasma
Lactate (mmol·L−1)
Control 1.2 ± 0.7 6.2 ± 2.0d 1.3 ± 0.4
Once-daily 0.9 ± 0.3 3.9 ± 1.0b,d 1.2 ± 0.4
Twice-a-day 1.4 ± 0.5 4.0 ± 1.6b,d 2.0 ± 0.7
Glucose (mmol·L−1)
Control 5.2 ± 0.8 5.5 ± 0.9 5.3 ± 0.8
Once-daily 5.2 ± 0.5 5.0 ± 0.8 b 4.8 ± 0.7b,c
Twice-a-day 4.4 ± 0.7a,b 4.8 ± 1.1b,d 4.3 ± 1.0a,b
Epinephrine (pg·mL−1)
Control 32.2 ± 18.4 39.3 ± 22.7 36.7 ± 17.8
Once-daily 56.7 ± 25.4 54.2 ± 25.7 35.8 ± 34.8
Twice-a-day 43.1 ± 13.6 43.7 ± 19.0 36.7 ± 10.4
Norepinephrine (pg·mL−1)
Control 68.0 ± 34.6 231.1 ± 141.8d 120.4 ± 90.3
Once-daily 70.7 ± 33.8 350.6 ± 139.8d 105.5 ± 77.5
Twice-a-day 76.7 ± 49.1 287.5 ± 147.6d 113.8 ± 44.6
Serum
Free Fatty Acid (µM)
Control 194.9 ± 118.2 118.6 ± 72.6 130.3 ± 72.1
Once-daily 155.5 ± 79.9 236.5 ± 151.4 158.0 ± 62.8
Twice-a-day 209.9 ± 125.5b 260.6 ± 151.3b 230.4 ± 98.2b
Glycerol (mmol·L−1)
Control 0.105 ± 0.021 0.098 ± 0.025 0.098 ± 0.037
Once-daily 0.090 ± 0.037 0.141 ± 0.022b 0.100 ± 0.039
Twice-a-day 0.106 ± 0.031 0.169 ± 0.046b 0.102 ± 0.023
Note: Data are presented as mean ± standard deviation. n = 8 for all variables.
aSignificantly different from the once-daily at the same time point (P < .05). 
bSignificantly different from the control condition at the same time point (P < .05). 
cSignificantly different from pre the high-intensity interval exercise for the same condition (P < .05). 
dSignificantly different from pre- and post the high-intensity interval exercise for the same condition, except for glucose that was significantly different only from 
post the high-intensity interval exercise (P < .05). Two-way analysis of variance (ANOVA) with Bonferroni post hoc test. 
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second exercise session with low muscle glycogen stores 
and/or performing the second exercise session close to 
the first. We investigated this question by performing the 
same exercise session with similar starting muscle glyco-
gen stores, but either 2 or 15 hours following the previous 
glycogen-lowering exercise session. Our results indicate 
that the greater exercise-induced nuclear protein abundance 
(TFEB and NFAT) and transcription of genes involved in 
mitochondrial biogenesis (PGC-1α, PPARα, PPARβ/δ) 
with the so-called “train-low” approach might be attributed 
to performing two exercise sessions in close proximity.
Despite the different recovery periods between exercise 
sessions for the two “train-low” approaches, muscle glycogen 
prior to the high-intensity interval exercise was reduced to a 
similar extent in both the twice-a-day and once-daily con-
dition compared with the control condition (Figure 2). This 
level of muscle glycogen concentration is consistent with 
previous studies that have utilized either the twice-a-day22,23 
or once-daily20 approach. In addition, muscle glycogen con-
centration before commencing the high-intensity exercise 
was below 300  mmol·kg−1·dry mass for both the twice-a-
day and once-daily conditions. Post the high-intensity inter-
val exercise muscle glycogen concentration remained above 
100 mmol·kg−1·dry mass. These values have been suggested 
as an “upper” and “lower” limit threshold, respectively, for 
which muscle glycogen levels may modulate genes related 
to mitochondrial biogenesis.54 Thus, the similar low muscle 
glycogen levels when commencing the high-intensity interval 
exercise in both “train-low” conditions allowed us to deter-
mine whether any differences for exercise-induced gene or 
protein expression could be attributed to performing high- 
intensity interval exercise with reduced muscle glycogen 
stores or to performing high-intensity interval exercise close 
to a previous exercise session.
In the present study, both p-AMPK- and p-p38 MAPK-
relative protein abundance in both the cytosolic and nucleus 
fractions was not altered with exercise or influenced by either 
“train-low” approach (Figure 4G,H). It has been suggested that 
the greater exercise-induced upregulation of cell-signaling 
pathways with reduced muscle glycogen content may be as-
sociated with enhanced nuclear and cytosolic abundance 
and greater activation of p-AMPK and p-p38 MAPK,15,16,55 
but contradictory results have been reported.20,22,26,56 For 
example, Cochran et al26 observed larger increases in cyto-
solic p-p38 MAPK but not p-AMPK with the twice-a-day 
approach, while Yeo et al22 reported larger increases in 
cytosolic p-AMPK but without alterations in p-p38 MAPK 
with the twice-a-day compared to the once-daily approach. 
On the other hand, Gejl et al56 and Psilander et al20 found no 
effect of either the twice-a-day or once-daily approach on both 
p-AMPK and p-p38 MAPK protein content in cytosolic frac-
tions. In addition, Chan et al15 and Steinberg et al16 reported 
an increase in nuclear abundance of p-p38 MAPK and AMPK, 
respectively, with the once-daily approach. The explanation 
for these contradictory results is unclear, but it is worth not-
ing both the glycogen-depleting exercise and the “depleted- 
exercise” varied considerably in these studies; either high-26,56 
or low-intensity15,16,20,22 exercise was used to reduce muscle 
glycogen, and high-22,26 or low-intensity15,16,20,56 exercise was 
implemented during the second exercise session (depleted- 
exercise). However, activation of AMPK and p38 MAPK does 
not seem to be associated with muscle glycogen levels or a 
particular train-low regime.57 Thus, it remains to be solved 
which protocol or strategy might induce augmented activation 
of p-AMPK and p-p38 MAPK.
Although p-AMPK and p-p38 MAPK relative protein 
abundance in the cytosolic and nucleus were not altered 
with exercise or “train-low” approaches, there was greater 
PGC-1α, p-p53, and p53 relative protein abundance in the 
nucleus immediately post the high-intensity interval exer-
cise (Figure 4C-E). There was also a higher p53 cytosolic 
protein abundance post the high-intensity interval exercise 
(Figure 3D). The increased nuclear and cytosolic p53 abun-
dance are consistent with the well-accepted notion that cellu-
lar stress is associated with accumulation of p53 protein—a 
process that has been partly attributed to increased p53 pro-
tein stability.58,59 Nevertheless, we found no significant dif-
ferences between either of the “train-low” approaches and 
the control condition for p-p53 and p53 relative protein abun-
dance in either subcellular fraction. The “train-low” approach 
has been associated with a greater exercise-induced cytosolic 
relative protein abundance of p-p53,17 which is suggested to 
influence the gene expression of PGC-1α.60 As differences 
in neither p-p53 nor p53 protein content in the nucleus could 
explain the greater exercise-induced increases in PGC-1α 
gene expression with the different train-low approaches 
in the present study, we subsequently investigated the 
nuclear abundance of other proteins that may contribute to the 
exercise-induced regulation of this gene.
The nuclear abundance of NFAT increased significantly 
after performing high-intensity interval exercise only in the 
twice-a-day condition, and post-exercise values were higher 
than both the control and once-daily conditions (Figure 4J). 
In addition, in both the pre- and postexercise muscle sam-
ples the nuclear abundance of TFEB was significantly greater 
with the twice-a-day compared to the once-daily approach 
(Figure 4I). As activated calcineurin dephosphorylates both 
NFAT61,62 and TFEB,63-65 leading to their translocation to the 
nucleus,61-66 this suggests there might be greater calcineurin 
activation when high-intensity interval exercise is performed 
soon after a prior exercise session. Although we did not 
have sufficient muscle sample to test this hypothesis, in the 
twice-a-day condition we observed significantly greater exer-
cise-induced increases of genes that have been reported to be 
regulated by calcineurin (eg, PGC-1α, PPARα, and PPARβ/
δ66,67).
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In contrast to our findings, some studies have reported 
greater exercise-induced increases in PGC-1α mRNA with 
the once-daily approach (~6-fold from rest) when com-
pared to a control condition (~3-fold from rest).17,19,20 This 
previously reported ~6-fold increase in PGC-1α mRNA 
with the once-daily approach is of similar magnitude to 
the PGC-1α mRNA increase with the once-daily approach 
in the present study (~6 fold from rest), although this was 
not significantly different to the change we observed in 
the control condition (~6-fold from rest). However, we did 
observe a significantly greater exercise-induced increase 
in PGC-1α (and PPARα, PPARβ/δ) mRNA content in the 
twice-a-day condition, even though muscle glycogen con-
tent before commencing the high-intensity interval exer-
cise was similar between the  twice-a-day and once-daily 
conditions, and both were lower than control. Our findings 
therefore suggest that the greater exercise-induced increase 
in these genes in our study can be attributed to perform-
ing the high-intensity interval exercise soon after the prior 
exercise session, rather than beginning the high-intensity 
interval exercise with lowered muscle glycogen levels. It 
should be mentioned, however, that carbohydrate might 
still play a role in myocellular signaling as ingesting exog-
enous carbohydrate between the two exercise sessions has 
been reported to block the stimulus for inducing oxidative 
enzyme adaptations in skeletal muscle.26,28
In the twice-a-day condition we also observed a greater 
circulating free fatty acid concentration pre-, post-, and 
3 hours post the high-intensity interval exercise (Table 2). 
Although respiratory exchange ratio values were always 
below 1.0 after the third interval, and systematically 
lower in the twice-a-day compared to the control condi-
tion (Figure 8), which could be indicative of greater fat 
oxidation, this conclusion is limited by the use of nonpro-
tein respiratory quotient to calculate substrate oxidation 
during nonsteady state exercise.68 The increase in circulat-
ing free fatty acids, however, might activate calcineurin69 
and regulate skeletal muscle metabolism via coordinated 
changes in gene expression.66 As previously mentioned, 
activated calcineurin will lead to the translocation of both 
NFAT and TFEB to the nucleus61-66 and the subsequent 
upregulation of genes related to fat metabolism.66 These 
exercise-induced changes are consistent with studies that 
have reported greater increases in fat oxidation when train-
ing twice-a-day.21,23
Caution is required when extrapolating the acute 
responses of exercising twice-a-day to the chronic effects 
of training with this approach. We have recently conducted 
a study comparing the magnitude of changes in molecu-
lar, functional, and morphological parameters linked to 
mitochondrial biogenesis after 3  weeks of twice-a-day 
or once-daily training.34 Despite similar improvements 
in endurance performance with both train-low strategies, 
markers of mitochondrial biogenesis (citrate synthase ac-
tivity and mitochondrial area) were not altered with either 
train-low approach.34 These findings could be interpreted 
to suggest that differences between twice-a-day and once-
daily approaches for the acute molecular responses associ-
ated with mitochondrial biogenesis might not be translated 
to different adaptations in mitochondrial content after a 
training period. However, 3  weeks of training might not 
be long enough to induce a significant increase in mito-
chondrial content.7 Three weeks of twice-a-day but not 
once-daily training did increase mitochondrial efficiency, 
which is in accordance with the assumption that functional 
alterations may precede morphological changes.70 Further 
research is required to determine if longer training period 
(ie, >3  weeks) using the twice-a-day approach results in 
greater changes in mitochondrial content.
Our study has some limitations that should be men-
tioned. First, as we were constrained by the number of 
muscle biopsies we could take, we elected to take our final 
muscle biopsy 3 hours post exercise as most of the key genes 
investigated in the present study have been reported to peak 
~3  hours after exercise (eg, PGC-1α and PPARβ/δ).5,71 
However, other genes might peak later (eg, CD-36)14 and 
we may have underestimated the influence of the two 
“train-low” approaches on some genes. Similarly, we did 
not perform muscle biopsies immediately and 3 hours after 
the muscle glycogen-depleting exercise; therefore, relevant 
changes in molecular signaling following the first exercise 
session in the once-daily condition may have been missed. 
Second, consistent with most related research,17,19,24,26-28 
we recruited participants who were active (~3.3 h of aero-
bic training per week) but who were not well-trained ath-
letes. While this may limit the applicability of our findings 
to elite athletes, it is difficult to perform similar experi-
ments requiring multiple muscle biopsies in well-trained 
athletes. Thus, further studies comparing different “train-
low” approached in well-trained athletes are required.
In summary, our findings indicate that the greater 
exercise-induced signaling with the so-called “train-low” 
approach in our study can partially be attributed to the per-
formance of two exercise sessions in close succession rather 
than exercising with a reduced muscle glycogen content. We 
presented evidence that performing two exercise sessions 
separated by a short recovery period increases the nuclear 
abundance of TFEB and NFAT and potentiates the transcrip-
tion of PGC-1α, PPARα, and PPARβ/δ.
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